Edwards Lifesciences Corporation (ew)
EW Valuation
| P/E (trailing) | 51.37 |
| P/E (forward) | 25.71 |
| EV/EBITDA | 23.34 |
| Price/Sales | 7.68 |
| Price/Book | 4.71 |
| Market cap | $50.04B |
Start Free — open EW in Vest Terminal
Access live data, filings, ownership, and analysis for Edwards Lifesciences Corporation.
Edwards Lifesciences Corporation FAQ
What does Edwards Lifesciences Corporation (EW) do?
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart val…
What is EW's P/E ratio?
Edwards Lifesciences Corporation has a trailing P/E of 51.37× based on publicly available market data.
Does EW pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is EW in?
Edwards Lifesciences Corporation is classified in Healthcare (Medical Devices) on NYQ.
What is EW's market capitalization?
Approximate market cap: $50.04B.
What are the main risks for EW?
Key risks include elevated valuation, among factors on this page.
What are the strengths of EW?
Potential positives include revenue growth of 13.6% year-over-year, gross margin of 77.8% supports competitive unit economics.
Where can I get analyst estimates for EW?
Public analyst price targets and consensus for Edwards Lifesciences Corporation are on the free /stocks/ew/estimates page. Deeper estimate history and models are available in Vest Terminal.